Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$1.55B |
| 2 |
Comcast
CMCSA
|
+$449M |
| 3 |
SLB Ltd
SLB
|
+$298M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$281M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$229M |
| 2 |
Sempra
SRE
|
+$192M |
| 3 |
Bausch Health
BHC
|
+$183M |
| 4 |
BNY
Bank of New York Mellon
BNY
|
+$175M |
| 5 |
PepsiCo
PEP
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.58% |
| 2 | Energy | 11.62% |
| 3 | Consumer Discretionary | 8.89% |
| 4 | Financials | 8.63% |
| 5 | Technology | 8.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESGR
2926
DELISTED
Enstar Group
ESGR
| $285K | ﹤0.01% |
+1,899
| New | +$294K |
|
2927
MasTec
MTZ
$20.5B
| $285K | ﹤0.01% |
18,000
-833,427
| -98% | -$14.5M |
|
|
CNW
2928
CALL
DELISTED
CON-WAY INC.
CNW
| $285K | ﹤0.01% |
+6,000
| New | +$235K |
|
2929
Cardiff Oncology
CRDF
$77.6M
| $284K | ﹤0.01% |
+693
| New | +$363K |
|
2930
Paylocity
PCTY
$8.09B
| $284K | ﹤0.01% |
+9,465
| New | +$322K |
|
2931
Twin Disc
TWIN
$326M
| $284K | ﹤0.01% |
+22,861
| New | +$339K |
|
|
FFIC
2932
DELISTED
Flushing Financial
FFIC
| $283K | ﹤0.01% |
+14,124
| New | +$289K |
|
2933
Global Indemnity Group
GBLI
$399M
| $283K | ﹤0.01% |
+10,799
| New | +$296K |
|
2934
VanEck Pharmaceutical ETF
PPH
$1.02B
| $283K | ﹤0.01% |
4,500
-7,267
| -62% | -$511K |
|
|
GNCMA
2935
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $282K | ﹤0.01% |
16,338
-48,217
| -75% | -$847K |
|
2936
Lindsay Corp
LNN
$1.18B
| $281K | ﹤0.01% |
4,144
-10,318
| -71% | -$818K |
|
2937
Natera
NTRA
$47.2B
| $281K | ﹤0.01% |
+25,936
| New | +$440K |
|
2938
Towne Bank
TOWN
$3.5B
| $281K | ﹤0.01% |
14,901
-19,762
| -57% | -$354K |
|
2939
National Presto Industries
NPK
$1.11B
| $280K | ﹤0.01% |
3,326
-2,933
| -47% | -$238K |
|
2940
Camden National
CAC
$961M
| $279K | ﹤0.01% |
+10,356
| New | +$276K |
|
2941
WD-40
WDFC
$2.9B
| $279K | ﹤0.01% |
+3,136
| New | +$273K |
|
|
VSLR
2942
DELISTED
VIVINT SOLAR, INC.
VSLR
| $279K | ﹤0.01% |
+26,612
| New | +$343K |
|
|
CEMP
2943
CALL
DELISTED
Cempra, Inc.
CEMP
| $278K | ﹤0.01% |
+10,000
| New | +$371K |
|
|
AHT
2944
Ashford Hospitality Trust
AHT
$21.5M
| $277K | ﹤0.01% |
46
-215
| -82% | -$1.71M |
|
|
MN
2945
DELISTED
MANNING & NAPIER, INC.
MN
| $277K | ﹤0.01% |
37,670
-159,749
| -81% | -$1.52M |
|
|
GBSN
2946
DELISTED
GREAT BASIN SCIENTIFIC INC COM PAR $.0001 NEW
GBSN
| $277K | ﹤0.01% |
+16
| New | +$4.28M |
|
2947
Gaia
GAIA
$37.4M
| $276K | ﹤0.01% |
44,946
+18,016
| +67% | +$115K |
|
2948
iShares Russell Mid-Cap Growth ETF
IWP
$20.4B
| $276K | ﹤0.01% |
+6,228
| New | +$295K |
|
|
OMN
2949
DELISTED
OMNOVA Solutions Inc.
OMN
| $276K | ﹤0.01% |
49,827
+26,194
| +111% | +$168K |
|
|
CELGZ
2950
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
| $275K | ﹤0.01% |
170,590
-84,660
| -33% | -$163K |
|
Similar funds
Israel Englander's Q3 2015 Portfolio in Review
As of Q3 2015, Israel Englander held 4,098 positions worth $51.6B, down 2.3% from $52.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Israel Englander deployed $5.12B of net new capital in Q3 2015, opening 839 new positions and adding to 1,320 existing holdings. Its largest new stake was BP: 4,551,492 shares worth $117M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 15% a quarter earlier, followed by Energy and Consumer Discretionary.
On the sell side, the largest reduction was Alexion Pharmaceuticals, an estimated $229M trimmed.
- Israel Englander's largest Q3 2015 buy was BP: 4,551,492 shares worth $117M.
- Israel Englander added most to DuPont de Nemours in Q3 2015, an estimated $1.55B increase.
- Israel Englander's biggest Q3 2015 reduction was Alexion Pharmaceuticals, cutting an estimated $229M.
- Israel Englander fully exited PepsiCo in Q3 2015, selling an estimated $173M.
- Israel Englander's ten largest holdings make up 14% of its $51.6B portfolio in Q3 2015.
- Israel Englander opened 839 new positions and closed 681 in Q3 2015.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $51.6B.
Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.